Obesity Trial, Recruiting NCT04942093 Sponsor: University Hospital, Rouen Condition: Obesity
Back to Obesity

Obesity Trial, Recruiting

NCT04942093
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have been approved for bariatric (weight loss) surgery and are scheduled to have a sleeve gastrectomy (a procedure that reduces the size of the stomach)
  • People with a BMI of 40 or higher (classified as morbid obesity)
  • People aged 18 to 65 years old
  • People whose haemoglobin (a measure of red blood cells in the blood) is at least 12 g/dL for men and at least 11 g/dL for women
  • People who speak and understand French
  • People who have read and understood the study information and have signed a consent form
  • Women of childbearing age who are using effective contraception (such as the pill, an intrauterine device, or tubal ligation) before surgery, and who have a negative pregnancy blood test at the time of joining the study, for the full duration of the study
  • Women who have gone through menopause, confirmed by at least 12 months without a period that was not caused by medication
  • People who are enrolled in or covered by a French social security (health insurance) scheme

Who may not be able to join:

  • People found to have a medical reason that prevents them from safely having bariatric surgery, identified during pre-surgery assessments
  • People who have a medical reason that prevents them from following a restricted diet
  • People with Type 1 or Type 2 diabetes who require insulin
  • People with severe kidney disease, where the kidneys are filtering blood at less than 30 mL/min
  • People who have a pacemaker or a similar implanted medical device (such as a cochlear implant or bladder stimulator)
  • People who are in legal custody or who are under a court-ordered form of legal protection or guardianship
  • People with a history of illness, psychological condition, or sensory impairment that may prevent them from fully understanding what participation involves or from giving informed consent

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 6 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +33232888624

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
University Hospital, Rouen
Registry
ClinicalTrials.gov
Start date
9 October 2023
Est. completion
20 November 2026

Where this trial is recruiting

🇫🇷 France

Primary endpoints

Poor diet tolerance

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 6 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov